Admission Date:  [**2122-1-15**]              Discharge Date:   [**2122-1-20**]  Date of Birth:  [**2064-12-22**]             Sex:   M  Service: MEDICINE  Allergies: No Known Allergies / Adverse Drug Reactions  Attending:[**First Name3 (LF) 8404**] Chief Complaint: respiratory failure  Major Surgical or Invasive Procedure: intubation, mechanical ventialtion  History of Present Illness:  Mr. [**Known lastname **] is a 57 year old man with a history of relapsed multiple myeloma who presents with mental status changes.
Per his records, he called his oncologist's office on [**2121-1-14**] with increased daytime sleepiness.
He was last seen by his oncologist on [**2122-1-5**] and was due to start his 4th cycle of Velcade, bendamustine and dexamethasone but this was held due to low blood counts.
A stat head CT showed air-fluid levels in the maxillary sinuses without intracranial hemorrhage.
He was tachypneic and there are reports of hemoptysis.
He reportedly became more hypoxic, lethargic and tachypneic and was intubated.
Bacterial Endocarditis [**2120-5-10**] Atrial Fibrillation Hypertension Anemia Hypercholesterolemia Obesity Coagulation Disorder with Elevated PT/PTT .
Oncologic History [**2117**]: Evaluated for anemia, bone soreness and coagulopathy, found to have MM with IgG level of 1.7g with monoclonal IgG lambda spike.
Had extensive bony lesions and renal insufficiency.
[**11-11**]: XRT to right femoral neck and L4 spinus process which had a pathological fracture.
Tried thalomid and revlimid but did not tolerate either [**2-10**]: Bmbx showed minimal but persistent involvement with plasma cell dyscrasia, 8% plasma cells.
[**Date range (1) 88308**] maintained on decadron alone [**1-14**]:: developed progression of disease with soft tissue mass at T9-T10 causing cord compression, started high-dose dexamethasone.
XRT T8-T10 at [**Company 2860**] [**Location (un) 5871**] [**2-11**]: Started Velcade/Decadron, but hospitalized x 2 duet o recurrent fevers, found to have small vegetation on aortic vavle but no positive blood cultures.
Treated emperically with doxycycline due to possible Bartonella, acyclovir, bactrim.
[**2121-6-29**]: Revlimid started 5mg/day [**2121-7-7**]: BmBx 30% plasma cells, Revlimid increased to 10mg/day [**2121-8-13**]: free lambda light chains 137; Revlimid increased to 20mg and dexamethasone 40mg weekly added [**2121-9-11**]: Revlimid d/c'd due to increasing light chains and cytopenias [**2121-10-7**]: resumed cyclophosphamide, velcade, dexamethasone and had progression after 1 cycle [**2121-10-27**]: chemotherapy switched to bendamustine, velcade, dexamethasone, received 3 cycles so far .
No blood in ETT.
RESP: CTA b/l with good air movement throughout CV: tachycardic, S1 and S2 wnl, no m/r/g ABD: nd, +b/s, soft, nt, no masses or hepatosplenomegaly EXT: 3+ pitting edema of feet and anterior shins bilaterally.
Cool extremities.
2+ peripheral pulses.
Brief Hospital Course: 57M with a history of end-stage multiple myeloma who presented with AMS and Respiratory Failure.
Viral swab was positive for RSV and he was found to have sepsis with e.coli + psudomonal bacteremia with likely foci of infection being pneumonia and UTI.
He also had air-fluid levels in his maxilary sinuses concerning for sinus infection.
Wide-spectrum antibiotics were administered as well as an anti-fungal [**Doctor Last Name 360**] for possible fungal infection in the setting of his immune supression.
His hospital course was complicated by oliguric renal failure and pancytopenia with no response to antibiotics and supportive therapy including IV fluids and blood products.
On hospital day 6, in view of his end-stage underlying condition and the development of multi-organ failure and in keeping with his family's wishes goals of care were changed to focus on comfort, patient was extubated and expired shortly thereafter with his family at the bedside.
